Animal Biotechnology Market Size Worth $ 56,949.40 Million By 2032 | CAGR: 8.8%
The global animal biotechnology market size is expected to reach USD 56,949.40 million by 2032, according to a new study by Polaris Market Research. The report “Animal Biotechnology Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Companion and Livestock); By Product Type; By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market is witnessing a rise in demand due to the genetic engineering of animals for various purposes, such as pharmaceutical, agricultural, and industrial applications. Animals with improved growth rates, disease resistance, and the ability to produce therapeutic proteins have been developed through animal biotechnology. The market is driven by the increasing need for diagnostic techniques to identify animal diseases, the availability of therapeutic options for treatment, and the development of pharmaceuticals and veterinary vaccines for preventive care.
Other growth drivers include the demand for genetically altered therapeutic proteins, the use of animals in cancer treatment, and the expansion of preventative care for pets. Factors such as animal welfare concerns, animals' role in human pharmaceutical development, increased animal adoption, and the demand for animals in agriculture and meat production further contribute to the market's growth.
The COVID-19 pandemic has had a significant impact on the animal biotechnology market. Disruptions in routine medical treatments, including immunizations, have affected animal health and welfare. Additionally, delays in delivering veterinary services due to pandemic-related constraints and subsequent surges in workload have further impacted the market. However, with the government's increasing initiatives and programs to enhance animal health, the demand for animal health technology is expected to rise in the coming years.
Animal Biotechnology Market Report Highlights
- The livestock segment dominates the market due to increasing global demand for livestock products and the use of biotechnological tools to improve productivity, health, and breed development.
- Veterinary hospitals and clinics lead in revenue with diverse treatment options. Zoonotic disease rise prompts demand for veterinary diagnostics, fueling the future growth of in-house or point-of-care testing.
- North America dominates the market due to its advanced healthcare infrastructure, emphasis on animal health, the concentration of biotechnology companies, favorable government initiatives, and supportive regulatory frameworks.
- The global key market players include Bayer AG, Boehringer Ingelheim International GmbH, Biogenesis Bago, Ceva, CSL Limited, Elanco, Heska Corporation, Hester Biosciences Limited, Idexx Laboratories, Id Vet India Pvt. Ltd, Indian Immunological Ltd, Intervet International B.V, Kareo Inc, Merck, Novartis AG, NXGN Management LLC, Pfizer Inc, Santa Cruz Biotechnology Inc, Zoetis Inc.
Request a free sample copy or read the full market insights: Animal Biotechnology Market
Polaris Market Research has segmented the Animal Biotechnology market report based on animal type, product type, application, end-use, and region:
Animal Biotechnology, Animal Type Outlook (Revenue - USD Million, 2019 - 2032)
- Companion
- Dogs
- Horses
- Cats
- Others
- Livestock
- Poultry
- Swine
- Cattle
- Fish
- Sheep/Goats
- Others
Animal Biotechnology, Product Type Outlook (Revenue - USD Million, 2019 - 2032)
- Drugs
- Diagnostic Test
- Vaccinations
- Feed Additives
- Reproductive and Genetic
Animal Biotechnology, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Food safety & Drug Development
- Preventive care of Animals
- Treatment of Animal Diseases
- Diagnosis of Animal Diseases
- Others
Animal Biotechnology, End-Use Outlook (Revenue - USD Million, 2019 - 2032)
- Veterinary Hospitals and clinics
- Point of care testing or In– House Testing
- Laboratories
- Others
Animal Biotechnology, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Animal Biotechnology Market Report Scope
| Report Attributes | Details |
| Market size value in 2023 | USD 26,561.97 million |
| Revenue forecast in 2032 | USD 56,949.40 million |
| CAGR | 8.8% from 2023 – 2032 |
| Base year | 2022 |
| Historical data | 2019 – 2021 |
| Forecast period | 2023 – 2032 |
| Quantitative units | Revenue in USD million and CAGR from 2023 to 2032 |
| Segments Covered | By Animal Type, By Product Type, By Application, By End-Use, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
| Key Companies | Bayer AG, Boehringer Ingelheim International GmbH, Biogenesis Bago, Ceva, CSL Limited, Elanco, Heska Corporation, Hester Biosciences Limited, Idexx Laboratories, Id Vet India Pvt. Ltd, Indian Immunological Ltd, Intervet International B.V, Kareo Inc, Merck, Novartis AG, NXGN Management LLC, Pfizer Inc, Santa Cruz Biotechnology Inc, Zoetis Inc. |
| For Specific Research Requirements |
